The CSMI recommends RSV vaccination for newborns due to the potential severity of lung and respiratory infections, particularly in young children. Dr Silvana Masi, a CSMI member, notes that approximately 60% of children contract RSV during their first year of life.
The period from October to March witnesses the highest circulation of the virus, with RSV cases typically diminishing after March. This timing aligns with the CSMI’s vaccination recommendation, starting on 1 October.
The product, known as “Nirsevimap,” consists of pre-produced antibodies administered via syringe, similar to a conventional vaccine. Mild side effects, such as slight fever or temporary irritability, are possible, mirroring typical reactions to medications. These minor side effects can be effectively managed with common remedies like paracetamol, according to Dr Masi.
The extent of RSV cases in Luxembourg’s maternity wings during the upcoming winter remains uncertain and will depend on the virus’s virulence. Dr Masi emphasises that RSV-related bronchiolitis is a leading cause of emergency room visits and hospitalisations in Luxembourg, accounting for more than 70% of cases.
In 2022, emergency rooms in Luxembourg faced substantial overcrowding, partially attributed to RSV-induced bronchiolitis. This surge was likely influenced by reduced virus exposure among children during the pandemic, although Dr Masi notes that similar scenarios had occurred in previous years.
Full report by RTL Télé (in Luxembourgish)
